Bio-Rad Launches External Quality Assurance Services Specialty Immunoassay Program
The External Quality Assurance Services Specialty Immunoassay program offers a external quality assessment for 13 key immunoassay analytes.
Read MorePosted by Andy Lundin | Oct 18, 2024 | Quality Control Programs |
The External Quality Assurance Services Specialty Immunoassay program offers a external quality assessment for 13 key immunoassay analytes.
Read MorePosted by Andy Lundin | Oct 9, 2024 | Leukemia |
Researchers have developed a CRISPR-based diagnostic test that accurately detects gene fusions in APL and CML within two hours.
Read MorePosted by Andy Lundin | Aug 23, 2024 | Controls |
Bio-Rad launched a new liquid specialty IA control designed to enhance lab precision and efficiency in specialty immunoassay testing.
Read MorePosted by Andy Lundin | Jul 2, 2024 | Heart Disease |
Measuring blood levels of homocysteine can help predict the risk and progression of obstructive sleep apnea.
Read MorePosted by Andy Lundin | Dec 28, 2023 | Kidney Disease, Standards |
The NIST released new standard reference material that uses urine to check for kidney disease and conditions that affect kidney function.
Read More